Search results
23 wrz 2022 · A total of 2900 premenopausal women with early breast cancer (mean [SD] age at diagnosis, 43.1 [5.6] years) were included in the present analysis (Figure 1; Table 1). At diagnosis, 2088 of 2661 patients (78.5%) had partnered status, and 2498 of 2602 patients (96.0%) had children.
Among women who used the levonorgestrel-releasing intrauterine device (LNG-IUD), the relative risk of breast cancer was 1.21 (95% CI, 1.11–1.33) compared with never-users of hormonal contraception, but the risk did not increase with duration of use.
21 mar 2023 · Conditional logistic regression yielded odds ratios (ORs) and 95% confidence intervals (CIs) of breast cancer by the hormonal contraceptive type last prescribed, controlled for age, GP practice, body mass index, number of recorded births, time since last birth, and alcohol intake.
7 gru 2017 · Studies of breast-cancer risk among women who receive hormonal contraceptives show inconsistent findings — from no elevation in risk to a 20 to 30% increase in risk. 12–29 Most studies have...
16 paź 2024 · By Nina Agrawal. Published Oct. 16, 2024 Updated Oct. 17, 2024. A study published Wednesday found that women using contraceptive intrauterine devices that deliver a certain hormone are at...
1 mar 2021 · Because many breast cancers are ER/PR positive, there is concern that exogenous hormones could increase the risk of recurrence by stimulating remaining breast tissue or clinically occult circulating metastatic ER/PR expressing breast cancer cells.
29 lip 2022 · Current use of progestogen-only methods is associated with a small increased risk of developing breast cancer, whereas we could only detect an increased risk among users of combined HC during the first five years of use.
